Empagliflozin in Hypertrophic Cardiomyopathy
Clinical trial NCT05182658 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05182658
- Sponsor
- National Institute of Cardiology, Warsaw, Poland
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2026-09-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.